| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/19/2007 | CN100337669C Externally applied medicine for curing pain and process for preparing the same |
| 09/19/2007 | CN100337649C Medicine for treating rheumatic arthritis and its preparing method |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271289 4'-(azetidin-1-ylcarbonyl)-N-cyclopropyl-5-fluoro-6-methyl-1,1'-biphenyl-3-carboxamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 09/18/2007 | US7271266 Sucha as methyl 2-(benzyloxy)-6-(4-chlorophenyl)-5-(phenyl)pyridine-3-carboxylate; For therapy and prophylaxis of psychosis, memory deficits, cognitive disorders, migraine, neuropathy, neuro-inflammatory disorders including multiple sclerosis and Guillain-Barre syndrome, stress, epilepsy |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271172 Pyrrolidine and azetidine compounds as CCR5 antagonists |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271152 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2414680C Methods for treating inflammation-mediated conditions of the eye |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2259621C Isocoumarin derivatives and their use in medicines |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 09/18/2007 | CA2176719C Fatty acid delivery system |
| 09/18/2007 | CA2124605C Prevention and improvement of medical symptoms caused by leucotriene b4 |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/18/2007 | CA2032859C Method of reducing or preventing adverse effect of steroid therapy and compositions therefor |
| 09/13/2007 | WO2007104030A1 Retinoids and related compounds for the treatment of neuroinflammatory conditions, diseases and disorders |
| 09/13/2007 | WO2007102769A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102768A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them . |
| 09/13/2007 | WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102410A1 Novel use of rage polypeptide |
| 09/13/2007 | WO2007102392A1 Mmp-13-selective inhibitor |
| 09/13/2007 | WO2007102019A1 The use of bupropion metabolites for the treatment of inflammatory disorders |
| 09/13/2007 | WO2007102011A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007102008A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007101641A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 09/13/2007 | WO2007101365A1 New flavane compound and its uses |
| 09/13/2007 | WO2007082208A3 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 09/13/2007 | WO2007071055A8 Compositions and methods for modulating gated ion channels |
| 09/13/2007 | WO2007065128A3 Human alpha-defensins inhibit interleukin-1beta release |
| 09/13/2007 | US20070213546 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 09/13/2007 | US20070213406 Anti-Inflammatory Analgesic External Aqueus Liquid Preparation |
| 09/13/2007 | US20070213402 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213361 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213332 Prodrugs Of Substituted Amino Heterobicycles Which Modulate The Function Of The Vanilloid-1 Receptor (Vr1) |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators |
| 09/13/2007 | CA2646884A1 The use of bupropion metabolites for the treatment of inflammatory disorders |
| 09/13/2007 | CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2645168A1 Use of light-active indocyanine green for treating inflammatory disorders in the oral cavity |
| 09/13/2007 | CA2645031A1 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 09/13/2007 | CA2644421A1 Use of vx-702 for treating rheumatoid arthritis |
| 09/12/2007 | EP1832657A1 Methylation of plasmid vectors |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1832284A1 Adiponectin inducer or secretagogue |
| 09/12/2007 | EP1831257A1 Humanized antibody specific for tumor necrosis factor-alpha |
| 09/12/2007 | EP1831227A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 09/12/2007 | EP1831225A2 Anti-inflammatory pyrazolopyrimidines |
| 09/12/2007 | EP1831215A1 Pyrido[2,3-d]pyrimidines as anti-inflamatory agents |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1831164A1 Heterocyclic compounds as ccr2b antagonists |
| 09/12/2007 | EP1830853A2 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 09/12/2007 | EP1830824A1 Nanoparticle composition and methods for synthesis thereof |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1526851B1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1406616B1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 09/12/2007 | EP1404640B1 Hydroxybutyric acid esters of acetylsalicylic acid, their methods of production and application as well as drugs containing them |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | EP0994867B1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 09/12/2007 | EP0842268B1 Methods and compositions for identifying morphogen analogs |
| 09/12/2007 | CN101035891A Lecithinized superoxide dismutase composition and process for producing the same |
| 09/12/2007 | CN101035782A Mif-inhibitors |
| 09/12/2007 | CN101035775A New hydroxymethylbenzothiazoles amides |
| 09/12/2007 | CN101035520A CRP lowering agent |
| 09/12/2007 | CN101033198A Compound of N-substituted-2,4-dichloro-5-fluorobenzamide, preparation and application thereof |
| 09/12/2007 | CN101033197A Pharmaceutical for preventing and treating fever and preparation thereof |
| 09/12/2007 | CN101032647A Instruments for medicine acupuncture and moxibustion |
| 09/12/2007 | CN101032612A Medicine preparation for curing inflammation and tumour and its prepn process |
| 09/12/2007 | CN101032610A Medicinal liquor with Chinese medicine for treating rheumatoid disease and its preparation |
| 09/12/2007 | CN101032606A Chinese traditional composition for external use for curing periarthritis of shoulder |
| 09/12/2007 | CN101032605A Compatibility of medicines fumigant for eliminating rheumatism pain |
| 09/12/2007 | CN101032604A Chinese medicine preparation for curing vascular type headache |
| 09/12/2007 | CN101032580A Medicine for treating rheumatic diseases |
| 09/12/2007 | CN101032568A Medicine for treating osteoproliferation |
| 09/12/2007 | CN101032566A Powder for external application for defervescence |
| 09/12/2007 | CN101032557A Fupian granulae and the preparing method |
| 09/12/2007 | CN101032549A Producing method of ointment for external use |
| 09/12/2007 | CN101032544A Medicine composition of compound honeysuckle organic acid and the preparing method of the agent thereof |